Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Has the yearly increase in the renal replacement therapy population ended?

Rosansky SJ, Clark WF.

J Am Soc Nephrol. 2013 Sep;24(9):1367-70. doi: 10.1681/ASN.2013050458. Epub 2013 Jul 18.

2.

An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006.

Kramer A, Stel V, Zoccali C, Heaf J, Ansell D, Grönhagen-Riska C, Leivestad T, Simpson K, Pálsson R, Postorino M, Jager K; ERA-EDTA Registry..

Nephrol Dial Transplant. 2009 Dec;24(12):3557-66. doi: 10.1093/ndt/gfp519. Epub 2009 Oct 9.

PMID:
19820003
3.

Regional and social inequalities in chronic renal replacement therapy in Denmark.

Hommel K, Rasmussen S, Kamper AL, Madsen M.

Nephrol Dial Transplant. 2010 Aug;25(8):2624-32. doi: 10.1093/ndt/gfq110. Epub 2010 Mar 5.

PMID:
20207710
4.

Global variation in renal replacement therapy for end-stage renal disease.

Caskey FJ, Kramer A, Elliott RF, Stel VS, Covic A, Cusumano A, Geue C, Macleod AM, Zwinderman AH, Stengel B, Jager KJ.

Nephrol Dial Transplant. 2011 Aug;26(8):2604-10. doi: 10.1093/ndt/gfq781. Epub 2011 Jan 18.

PMID:
21245131
5.

ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.

McDonald SP, Russ GR, Kerr PG, Collins JF; Australia and New Zealand Dialysis and Transplant Registry..

Am J Kidney Dis. 2002 Dec;40(6):1122-31.

PMID:
12460029
6.

Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999.

Stengel B, Billon S, Van Dijk PC, Jager KJ, Dekker FW, Simpson K, Briggs JD.

Nephrol Dial Transplant. 2003 Sep;18(9):1824-33.

PMID:
12937231
7.

Renal replacement therapy for rare diseases affecting the kidney: an analysis of the ERA-EDTA Registry.

Wühl E, van Stralen KJ, Wanner C, Ariceta G, Heaf JG, Bjerre AK, Palsson R, Duneau G, Hoitsma AJ, Ravani P, Schaefer F, Jager KJ.

Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv1-8. doi: 10.1093/ndt/gfu030.

PMID:
25165174
8.

End-stage renal disease in the USA: data from the United States Renal Data System.

Agodoa LY, Jones CA, Held PJ.

Am J Nephrol. 1996;16(1):7-16.

PMID:
8719761
9.

Medical practice patterns and socio-economic factors may explain geographical variation of end-stage renal disease incidence.

Couchoud C, Guihenneuc C, Bayer F, Lemaitre V, Brunet P, Stengel B; REIN Registry..

Nephrol Dial Transplant. 2012 Jun;27(6):2312-22. doi: 10.1093/ndt/gfr639. Epub 2011 Nov 25.

PMID:
22121236
10.

Renal replacement therapy in Canada: a report from the Canadian Organ Replacement Register.

Fenton S, Desmeules M, Copleston P, Arbus G, Froment D, Jeffery J, Kjellstrand C.

Am J Kidney Dis. 1995 Jan;25(1):134-50.

PMID:
7810519
11.

Late initiation of dialysis among women and ethnic minorities in the United States.

Kausz AT, Obrador GT, Arora P, Ruthazer R, Levey AS, Pereira BJ.

J Am Soc Nephrol. 2000 Dec;11(12):2351-7.

12.

Survival trends in ESRD patients compared with the general population in the United States.

van Walraven C, Manuel DG, Knoll G.

Am J Kidney Dis. 2014 Mar;63(3):491-9. doi: 10.1053/j.ajkd.2013.09.011. Epub 2013 Nov 6.

PMID:
24210591
13.

End stage renal disease in Brunei Darussalam - report from the first Brunei Dialysis Transplant Registry (BDTR).

Tan J.

Ren Fail. 2013 Sep;35(8):1101-4. doi: 10.3109/0886022X.2013.815101. Epub 2013 Jul 23.

PMID:
23879396
14.

Renal replacement therapy associated with lithium nephrotoxicity in Australia.

Roxanas M, Grace BS, George CR.

Med J Aust. 2014 Mar 3;200(4):226-8.

PMID:
24580527
15.

Timing and outcome of renal replacement therapy in patients with congenital malformations of the kidney and urinary tract.

Wühl E, van Stralen KJ, Verrina E, Bjerre A, Wanner C, Heaf JG, Zurriaga O, Hoitsma A, Niaudet P, Palsson R, Ravani P, Jager KJ, Schaefer F.

Clin J Am Soc Nephrol. 2013 Jan;8(1):67-74. doi: 10.2215/CJN.03310412. Epub 2012 Oct 18.

16.

Incidence of end stage renal disease on renal replacement therapy in Nepal.

Hada R, Khakurel S, Agrawal RK, Kafle RK, Bajracharya SB, Raut KB.

Kathmandu Univ Med J (KUMJ). 2009 Jul-Sep;7(27):301-5.

PMID:
20071881
18.

Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease.

Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Caskey F, Collart F, Finne P, Fogarty DG, Groothoff JW, Hoitsma A, Nogier MB, Postorino M, Ravani P, Zurriaga O, Jager KJ, Gansevoort RT; ERA-EDTA Registry.; EuroCYST Consortium.; WGIKD.; EuroCYST Consortium.; WGIKD..

Kidney Int. 2014 Dec;86(6):1244-52. doi: 10.1038/ki.2014.120. Epub 2014 May 14.

PMID:
24827775
19.

Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study.

Malberti F, Marcelli D, Conte F, Limido A, Spotti D, Locatelli F.

J Am Soc Nephrol. 2001 Jun;12(6):1242-8.

20.

Late dialysis start did not affect long-term outcome in Japanese dialysis patients: long-term prognosis from Japanese Society for [corrected] Dialysis Therapy Registry.

Yamagata K, Nakai S, Iseki K, Tsubakihara Y; Committee of Renal Data Registry of the Japanese Society for Dialysis Therapy..

Ther Apher Dial. 2012 Apr;16(2):111-20. doi: 10.1111/j.1744-9987.2011.01052.x. Erratum in: Ther Apher Dial. 2012 Jun;16(3):284-5.

PMID:
22458388

Supplemental Content

Support Center